Loading clinical trials...

Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00990847

Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma

The purpose of this study is to compare the efficacy and safety of nebule procaterol with nebule salbutamol in the treatment of moderate acute asthma.

Lead sponsor: PT Otsuka Indonesia•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment140

Start dateJun 2007

Last updatedOct 7, 2009

Condition

Moderate Acute Asthma

Locations shown

University of Indonesia/ Persahabatan Hospital

Jakarta

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 7, 2009Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions